We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / About Novasep / Media & Events / Press releases

Press releases

NOVASEP and THERAVECTYS enter into a new license agreement on DNA Flap Technology for GMP Manufacturing of lentiviral vectors

NOVASEP and THERAVECTYS enter into a new license agreement on DNA Flap Technology for GMP Manufacturing of lentiviral vectors

16 Apr 2019

This agreement supports the growing demand for lentivector-based gene therapies, immunotherapies and vaccines


Novasep announces the success of its consent solicitation extending the maturity of its notes

20 Feb 2019

• All resolutions were approved by 100% of the participating Noteholders and C Warrantholders
• Noteholders representing 99.9% of total outstanding principal amount participated


Enzene Biosciences chooses Novasep BioSC® Pilot chromatography for its automated end to end continuous manufacture of mAb.

Enzene Biosciences chooses Novasep BioSC® Pilot chromatography for its automated end to end continuous manufacture of mAb.

04 Feb 2019

Novasep, a leading supplier of services and technologies for the life sciences industry, announces Enzene Biosciences (India) has chosen BioSC® Pilot for purification of biopharmaceuticals to operate in its Pune plant.


Novasep announces the launch of a consent solicitation for the maturity extension of notes with requisite voting majority of the noteholders already secured

31 Jan 2019

Novasep Holding S.A.S (“Novasep”), a leading supplier of services and technologies for the life sciences industry, announces the launch of a consent solicitation (the “Consent Solicitation”) in order to, inter alia:


Novasep industrializes potato protein purification unit for Solanic B.V.

Novasep industrializes potato protein purification unit for Solanic B.V.

22 Oct 2018

This represents a step forward for the plant-based protein purification industry, with the first compact bed chromatography system for the purification of vegetable proteins.


Novasep opens €27m new Viral Vector Commercial Production Facility

Novasep opens €27m new Viral Vector Commercial Production Facility

02 Oct 2018

With this new Viral Vector bioproduction facility, Novasep confirms its leadership position and effectively addresses the growing gene therapy market demand


Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s

Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s

21 Aug 2018

Novasep’s robust quality assurance system, fully compliant with the highest world standards, showcased during successful FDA inspection of the Chasse-sur-Rhône (France) facility.


Novasep launches BioSC® Pilot, breakthrough chromatography and DSP skid for biologics purification

11 Jun 2018

BioSC Pilot® is a new tool for continuous and intensified downstream processes in the biopharmaceutical industry.


Novasep invests €10M in “SeneFill”, its new facility for commercial aseptic  Fill & Finish operations

Novasep invests €10M in “SeneFill”, its new facility for commercial aseptic Fill & Finish operations

02 May 2018

This facility, located in Seneffe (Belgium), will strengthen Novasep’s drug product services for mAbs, viral vectors and other low volume biopharmaceuticals


Novasep announces 2017 financial results

Novasep announces 2017 financial results

25 Apr 2018

Sales are up 4% at 282 M€
EBITDA is up 4.3% at 29 M€



You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!
.